Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

An unusual presentation of a more common disease entity

Charlotte Van de Kerkhove, Walter De Wever, Eric K. Verbeken, Christophe Deroose, Kris Nackaerts
Breathe 2018 14: 49-53; DOI: 10.1183/20734735.013417
Charlotte Van de Kerkhove
1Respiratory diseases, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vandekerkhove.charlotte@gmail.com
Walter De Wever
2Radiology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric K. Verbeken
3Dept of Pathology, KU Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Deroose
4Nuclear Medicine, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kris Nackaerts
5Respiratory Oncology, University Hospital Gasthuisberg, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Beware unusual presentations of more common disease entities, as in this interactive case report http://ow.ly/qj7f30eVFsp

A 66-year-old, male patient with a 10-pack-year history of smoking was referred to the internal medicine consultation because of a 4-week history of fatigue, weakness, intermittent low-grade fever, appetite and weight loss, and a mild dry cough. His previous history was unremarkable and his physical examination was normal. Routine laboratory screening revealed leukocytosis (11.08×109 leukocytes per L), elevated C-reactive protein (72.1 mg⋅L−1) and erythrocyte sedimentation rate 57 mm⋅h−1. Analyses for rheumatoid factor, antinuclear antibodies, and cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies were all negative. Pulmonary function tests (static and dynamic volumes, flow–volume curve, and lung diffusion capacity) were within the predictive values. Chest radiography demonstrated bilateral hilar enlargement. The patient subsequently underwent a computed tomography (CT) scan of the chest (figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Chest CT.

Task 1

Describe the imaging findings noted on the CT scan of the chest.

Answer 1

The images demonstrate a new spiculated lung nodule 2 cm in diameter in the left lower lobe (figure 1d). Hilar and mediastinal lymphadenopathies in positions 2R (figure 1a), 4L (figure 1b), 7 and 10L (figure 1c) are present.

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) was performed, showing hypermetabolic activity of the focal lung lesion (figure 2d), and moderate-to-strong FDG-positive left and right paratracheal, subcarinal and hilar mediastinal lymph nodes (figure 2).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Fusion PET-CT.

Task 2

What is your differential diagnosis and what is the most appropriate diagnostic step?

Answer 2

Lymph nodes may be enlarged for a variety of inflammatory, infectious or malignant reasons. Here, the differential diagnosis would be lung carcinoma, lymphoma, tuberculosis, sarcoidosis and organising pneumonia (OP). His smoking history and the PET pattern prioritised malignancy as a key differential diagnosis.

The next step should be an attempt to obtain lung tissue for histopathological diagnosis. Because the lung lesion was not easily accessible, the decision was made to proceed to endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of the enlarged lymph nodes.

Bronchoscopy with EBUS-TBNA of the lymph nodes in stations 4R, 4L and 7 was performed. The bronchoscopy findings were normal. Results of Gram and Ziehl–Neelsen stains on bronchoalveolar lavage fluid were negative. Cytological analysis of the lymph nodes revealed a neutrophilic cell infiltrate without malignant cells. Following multidisciplinary team discussion, a CT-guided, percutaneous, transthoracic needle biopsy of the left lower lobe mass was performed in order to rule out malignancy. Histological examination revealed thickening of the alveolar septa because of interstitial mononuclear inflammation, hyperplasia of type 2 cells and young, fibrotic, intra-alveolar plugs (figure 3).

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Histological examination of the transthoracic needle biopsy specimen (haematoxylin and eosin staining, 200×).

Task 3

What is the final diagnosis and how would you manage this patient?

Answer 3

The histological pattern of this lesion resembled that of OP. Because no underlying aetiology or associated disorder was found, cryptogenic organising pneumonia (COP) is the most likely diagnosis.

The management of COP has not been studied in prospective randomised trials, so treatment decisions are based on general clinical considerations including the severity of symptoms and the rapidity of disease progression. Corticosteroids are the current standard treatment, although the optimum dose and duration are less certain [1].

The patient was started on methylprednisolone 32 mg⋅day−1, which was gradually tapered, and stopped after 3 months. We observed a rapid clinical improvement and a gradual resolution of the abnormal CT findings on follow-up scans (figure 4).

Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4

Follow-up CT after a) 2 and b) 4 months showed marked improvement, with only a small, residual millimetric nodular lesion being present.

Discussion

COP, the idiopathic form of OP, formerly called “bronchiolitis obliterans organising pneumonia”, is a well described entity with characteristic clinicoradiological features and pathological diagnostic criteria [2]. COP can present with a wide variety of radiological manifestations. Three main imaging patterns may be distinguished:

  • multiple patchy alveolar opacities (typical pattern)

  • a solitary focal lesion (focal pattern like in our case)

  • diffuse bilateral infiltration

Definitive diagnosis of COP relies on finding of typical pathological and clinical–radiologic features, and the exclusion of possible causes or associated disorders [3, 4].

Focal organising pneumonia (FOP) is a rare form of OP and presents as an isolated focal lesion on chest imaging, which may mimic lung cancer [5]. Only sporadic FOP cases or small case series have been reported in the literature. FOP accounts for approximately 10–15% of all cases of OP and the majority of cases are cryptogenic [6, 7]. Patients are usually asymptomatic or mildly symptomatic and it is more frequent in middle-aged male smokers [6–8]. Reported CT features of FOP show a wide range of variations, including solitary or multiple nodules or masses with irregular margins and a round or oval shape [9]. FOP lesions are predominantly located in the periphery of the lungs. Mediastinal lymphadenopathy involvement is an uncommon feature in OP. A retrospective study by Niimi et al. [10] showed that enlarged mediastinal nodes were present in 36% (eight out of 22) of the patients with COP. Usually, only one or two nodal stations are enlarged. Althoff Souza et al. [11] reported detectable enlargement in 38% (six out of 16) patients with COP. The presence of enlarged nodes was less common in COP than in the other idiopathic interstitial pneumonias (p=0.04). In the series of Zhao et al. [12], mild mediastinal lymph node enlargement was present in ∼20% of the patients. To our knowledge, three previous cases of OP presenting with extensive lymphadenopathy have been reported in literature [13–15].

OP is one of the benign thoracic conditions that may cause false positive results on PET-CT. Data on increased FDG uptake in OP are limited. In the series of Baha et al. [16], hypermetabolic activity of the focal lung lesion was demonstrated in all 14 FOP cases with a median maximal standardised uptake value (SUVmax) of 3.5±2.7 (range 2.1–13.1). Erdoğan et al. [17] demonstrated hypermetabolism on FDG-PET in all radiological subtypes of OP, with a mean SUVmax of the lesions calculated as 6.5.

The diagnosis of FOP requires histopathological identification of a predominant pattern of OP, characterised by polypoid intraluminal plugs of proliferating fibroblasts and myofibroblasts within alveolar ducts and airspaces, with varying degrees of bronchiolar involvement [2–4]. Reports suggest that most patients underwent surgical resection of their lung lesion because of suspicion of lung cancer [7, 8, 12]. Although curative, pulmonary resection of FOP should be avoided, as it is unnecessary considering the benign nature of the disease and the efficacy of steroid therapy. CT-guided biopsy may be a valid alternative to more invasive procedures as shown in our case and in the series of Poulou et al. [18], where in all 14 patients, a single procedure yielded a diagnostic specimen.

Rapid clinical and imaging improvement is usually obtained with corticosteroid therapy. The efficacy of steroids has been widely documented, and steroids continue to be recommended as the first choice of therapy for patients with symptomatic and progressive COP [1, 4]. The majority of patients recover completely with oral corticosteroids but relapse is common.

Conclusion

The combination of a FDG-PET-positive solitary lung nodule with significantly enlarged bilateral hilar and mediastinal lymph nodes, as observed in the present case, initially strongly suggested the diagnosis of locally advanced lung cancer. FDG-PET cannot differentiate FOP from a malignant tumour but it can help guide invasive procedures that should be performed when there is suspicion of malignancy. The presence of mediastinal lymphadenopathy has been very rarely reported in patients with COP. Finally, this case highlights the importance of obtaining histological confirmation of a suspicious pulmonary lesion, not only for establishing a definitive diagnosis but also for the planning of invasive surgical treatment or not.

Footnotes

  • Conflict of interest None declared.

  • Copyright ©ERS 2018

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Bradley B,
    2. Branley HM,
    3. Egan JJ
    , et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63: Suppl. 5, v1–58.
    OpenUrlFREE Full Text
  2. ↵
    1. Epler GR,
    2. Colby TV,
    3. McLoud TC
    , et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152–158.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Cordier J-F,
    2. Loire R,
    3. Brune J
    . Idiopathic bronchiolitis obliterans organizing pneumonia: definition of characteristic clinical profiles in a series of 16 patients. Chest 1989; 96: 999–1004.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Cordier JF
    . Organising pneumonia. Thorax 2000; 55: 318–328.
    OpenUrlFREE Full Text
  5. ↵
    1. Lohr RH,
    2. Boland BJ,
    3. Douglas WW
    , et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997; 157: 1323–1329.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Watanabe K,
    2. Harada T,
    3. Yoshida M
    , et al. Organizing pneumonia presenting as a solitary nodular shadow on a chest radiograph. Respiration 2003; 70: 507–514.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Melloni G,
    2. Cremona G,
    3. Bandiera A
    , et al. Localized organizing pneumonia: report of 21 cases. Ann Thorac Surg 2007; 83: 1946–1951.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Maldonado F,
    2. Daniels CE,
    3. Hoffman EA
    , et al. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest 2007; 132: 1579–1583.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kohno N,
    2. Ikezoe J,
    3. Johkoh T
    , et al. Focal organizing pneumonia: CT appearance. Radiology 1993; 189: 119–123.
    OpenUrlPubMed
  10. ↵
    1. Niimi H,
    2. Kang EY,
    3. Kwong JS
    , et al. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 1996; 20: 305–308.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Althoff Souza C,
    2. Muller NL,
    3. Lee Kyung S
    , et al. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. Am J Roentgenology 2006; 186: 995–999.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Zhao F,
    2. Yan SX,
    3. Wang GF
    , et al. CT features of focal organizing pneumonia: an analysis of consecutive histopathologically confirmed 45 cases. Eur J Radiol 2014; 83: 73–78.
    OpenUrl
  13. ↵
    1. Varma S,
    2. Gupta S,
    3. Elsoueidi R
    , et al. Bilateral hilar lymphadenopathy in a young female: a case report. J Med Case Rep 2007; 1: 60.
    OpenUrl
    1. Ponnuswamy A,
    2. Mediratta N,
    3. Lyburn ID
    , et al. False positive diagnosis of malignancy in a case of cryptogenic organising pneumonia presenting as a pulmonary mass with mediastinal nodes detected on fluorodeoxyglucose-positron emission tomography: a case report. J Med Case Rep 2009; 3: 124.
    OpenUrl
  14. ↵
    1. Kahraman H,
    2. Tokur M,
    3. Sayar H
    , et al. Cryptogenic organising pneumonia presenting with bilateral hilar and mediastinal lymphadenopathy. BMJ Case Rep 2013; bcr2013009712.
  15. ↵
    1. Baha A,
    2. Yildirim F,
    3. Kokturk N
    , et al. 18F-FDG uptake in focal organising pneumonia mimicking bronchial carcinoma. Clin Respir J 2016; 10: 740–745.
    OpenUrl
  16. ↵
    1. Erdoğan Y,
    2. Özyürek BA,
    3. Özmen Ö
    , et al. The evaluation of FDG PET/CT scan findings in patients with organizing pneumonia mimicking lung cancer. Mol Imaging Radionucl Ther 2015: 5; 24: 60–65.
    OpenUrl
  17. ↵
    1. Poulou LS,
    2. Tsangaridou I,
    3. Filippoussis P
    , et al. Feasibility of CT-guided percutaneous needle biopsy in early diagnosis of BOOP. Cardiovasc Intervent Radiol 2008; 31: 1003–1007.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Vol 14 Issue 1 Table of Contents
Breathe: 14 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An unusual presentation of a more common disease entity
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
An unusual presentation of a more common disease entity
Charlotte Van de Kerkhove, Walter De Wever, Eric K. Verbeken, Christophe Deroose, Kris Nackaerts
Breathe Mar 2018, 14 (1) 49-53; DOI: 10.1183/20734735.013417

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
An unusual presentation of a more common disease entity
Charlotte Van de Kerkhove, Walter De Wever, Eric K. Verbeken, Christophe Deroose, Kris Nackaerts
Breathe Mar 2018, 14 (1) 49-53; DOI: 10.1183/20734735.013417
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Case report

  • Spontaneous pneumothorax or no pneumothorax at all?
  • A hint for abnormal thoracic shadow: look behind the heart
  • Cutaneous lesions in a COVID-19 patient leading to a surprising diagnosis
Show more Case report

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society